P3 Health CFO granted 30,000 stock options
P3 Health Partners Inc. reported that its Chief Financial Officer, Leif Elliott Pedersen, received a grant of stock options covering 30,000 shares of Class A common stock.
Rhea-AI Filing Summary
P3 Health Partners Inc. reported that its Chief Financial Officer, Leif Elliott Pedersen, received a grant of stock options covering 30,000 shares of Class A common stock. The options have an exercise price of $3.5479 per share, become exercisable on May 8, 2030, and expire on May 8, 2036. Following this award, Pedersen holds stock options for a total of 45,000 shares, reflecting a routine compensation-related equity grant rather than an open-market purchase or sale.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 30,000 shares
Grant/Award
1 txn
Insider
Pedersen Leif Elliott
Role
Chief Financial Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 30,000 | $3.5479 | $106K |
Holdings After Transaction:
Stock Option (Right to Buy) — 45,000 contracts (Direct)
Key Figures
Option grant size: 30,000 options
Exercise price: $3.5479 per share
Underlying shares: 30,000 shares
+3 more
6 metrics
Option grant size
30,000 options
Stock Option (Right to Buy) granted to CFO on May 8, 2026
Exercise price
$3.5479 per share
Conversion or exercise price of granted stock options
Underlying shares
30,000 shares
Class A common stock underlying the stock options
Post-grant option holdings
45,000 options
Total stock options held by CFO after this transaction
Exercise start date
May 8, 2030
Date when the options become exercisable
Expiration date
May 8, 2036
Date when the stock options expire
Key Terms
Stock Option (Right to Buy), exercise price, expiration date, grant, award, or other acquisition, +1 more
5 terms
Stock Option (Right to Buy) financial
"security_title: Stock Option (Right to Buy)"
exercise price financial
"conversion_or_exercise_price: 3.5479"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"expiration_date: 2036-05-08T00:00:00.000Z"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
grant, award, or other acquisition financial
"transaction_code_description: Grant, award, or other acquisition"
Class A Common Stock financial
"underlying_security_title: Class A Common Stock"
Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did P3 Health Partners (PIII) disclose about its CFO in this Form 4?
P3 Health Partners disclosed that Chief Financial Officer Leif Elliott Pedersen received a grant of stock options for 30,000 shares of Class A common stock as compensation, increasing his total stock option holdings to 45,000 shares following this award.
What is the exercise price of the CFO stock options at P3 Health Partners (PIII)?
The granted stock options have an exercise price of $3.5479 per share. This means the CFO can buy P3 Health Partners’ Class A common stock at $3.5479 per share once the options become exercisable, regardless of the market price at that time.
When do the new CFO stock options at P3 Health Partners (PIII) vest and expire?
The stock options granted to the CFO become exercisable on May 8, 2030, and expire on May 8, 2036. This provides a six-year exercise window after vesting, aligning the award with longer-term company performance and executive retention.
How many P3 Health Partners (PIII) stock options does the CFO hold after this grant?
After the reported grant, the CFO holds stock options for 45,000 shares of Class A common stock. The Form 4 indicates that 30,000 options were newly awarded, bringing his total derivative holdings to 45,000 options directly owned.
Is the P3 Health Partners (PIII) CFO Form 4 an open-market stock purchase or sale?
No, the Form 4 reflects a compensation-related stock option grant, not an open-market trade. The transaction is coded as a grant or award acquisition (code A), meaning the company awarded options rather than the CFO buying or selling shares in the market.
AI-generated analysis. How Rhea-AI works. Not financial advice.
